PMID- 30343350 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200929 IS - 2193-8210 (Print) IS - 2190-9172 (Electronic) VI - 8 IP - 4 DP - 2018 Dec TI - Clinical and Genetic Risk Factors Associated with Psoriatic Arthritis among Patients with Psoriasis. PG - 593-604 LID - 10.1007/s13555-018-0266-x [doi] AB - INTRODUCTION: Psoriatic arthritis (PsA) is a chronic, inflammatory arthritis that affects an estimated 30% of patients with psoriasis. PsA is underdiagnosed in primary care and dermatology clinics due to a variety of reasons, including failure of healthcare providers to ask about symptoms, overlap of symptoms and signs with other rheumatologic conditions, and lack of a specific diagnostic test. A delay in PsA diagnosis and treatment, even as short as 6 months, can lead to decreased quality of life, increased joint damage, and worse long-term physical function. In this study, we sought to identify the clinical and genetic factors that help discriminate patients with PsA from those with cutaneous psoriasis only. METHODS: We analyzed a cohort of 974 psoriasis patients at an academic medical center, of whom 175 had confirmed PsA, and performed univariate, multivariate, and predictive modeling to determine factors associated with PsA. RESULTS: The univariate analysis revealed significant positive associations of PsA with age, nail involvement, scalp involvement, skin fold involvement, elbow/knee involvement, psoriasis severity, plaque subtype, erythrodermic subtype, hypertension, type 2 diabetes, and coronary artery disease, and a significant negative association of PsA with the human leukocyte antigen (HLA)-C*06:02 allele. In the multivariate analysis, nail involvement, type 2 diabetes, and pustular psoriasis remained significantly associated with PsA, while HLA-C*06:02 positivity remained protective. There was a trend towards an association of PsA with older age, younger age of psoriasis onset, and skin fold involvement, while there was protective trend for smoking. A predictive model including both clinical and genetic factors showed reasonable discriminative ability between psoriasis and PsA, with an area under the curve of 0.87 for a receiver operating characteristic curve. CONCLUSION: This study identified a number of clinical and genetic features that could help stratify patients who are at higher risk for having PsA and for whom rheumatology referral may be beneficial. FAU - Yan, Di AU - Yan D AD - Department of Dermatology, University of California San Francisco, San Francisco, CA, USA. FAU - Ahn, Richard AU - Ahn R AD - Department of Microbiology, Immunology and Molecular Genetics, Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, CA, USA. FAU - Leslie, Stephen AU - Leslie S AD - Centre for Systems Genomics, Schools of Mathematics and Statistics, and BioSciences, The University of Melbourne, Melbourne, VIC, Australia. FAU - Liao, Wilson AU - Liao W AUID- ORCID: 0000-0001-7883-6439 AD - Department of Dermatology, University of California San Francisco, San Francisco, CA, USA. wilson.liao@ucsf.edu. LA - eng GR - R01 AR065174/AR/NIAMS NIH HHS/United States GR - U01 AI119125/AI/NIAID NIH HHS/United States PT - Journal Article DEP - 20181020 PL - Switzerland TA - Dermatol Ther (Heidelb) JT - Dermatology and therapy JID - 101590450 PMC - PMC6261122 OTO - NOTNLM OT - Association OT - Demographics OT - Genetics OT - Prediction OT - Psoriasis OT - Psoriatic arthritis OT - Risk EDAT- 2018/10/22 06:00 MHDA- 2018/10/22 06:01 PMCR- 2018/10/20 CRDT- 2018/10/22 06:00 PHST- 2018/07/23 00:00 [received] PHST- 2018/10/22 06:00 [pubmed] PHST- 2018/10/22 06:01 [medline] PHST- 2018/10/22 06:00 [entrez] PHST- 2018/10/20 00:00 [pmc-release] AID - 10.1007/s13555-018-0266-x [pii] AID - 266 [pii] AID - 10.1007/s13555-018-0266-x [doi] PST - ppublish SO - Dermatol Ther (Heidelb). 2018 Dec;8(4):593-604. doi: 10.1007/s13555-018-0266-x. Epub 2018 Oct 20.